Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment begins in phase IIa study of CC-31244 for the treatment of HCV-infected individuals

June 29, 2018

Preliminary data presented from the PIVOT-02 study of NKTR-214 plus nivolumab

June 29, 2018

Erimos Pharmaceuticals initiates phase I study of oral terameprocol

June 29, 2018

Inovio reports phase I results for INO-4700 in MERS

June 29, 2018

Kangpu initiates phase I study of KPG-121 for metastatic CRPC

June 29, 2018

FDA clears of IND application for OC-01 as treatment of dry eye disease

June 29, 2018

GBM cells spread their message beyond death

June 29, 2018

The locus of alcohol's reward

June 29, 2018

Alexion seeks E.U. approval for ALXN-1210 for PNH

June 28, 2018

Benefits seen with MEDI-0382 in overweight/obese subjects with type 2 diabetes

June 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...